NEW YORK, NY — March 3, 2002 — More than one-third of middle class, suburban children with moderate to severe asthma are not using controller medications, researchers reported at the 58th Annual Meeting of the American Academy of Allergy, Asthma, and Immunology (AAAAI).
According to guidelines published by the US National Institutes of Health, long-term controller medications are indicated to achieve and maintain control of persistent asthma.
The results also indicate that children treated by an allergist are much more likely to use controller medications than children seen by generalists.
Karen Callahan, MD, and associates at Johns Hopkins University in Baltimore, Maryland, evaluated the medical management of middle class children with persistent asthma and the use of controller medications using information drawn from 181 families of children with asthma. Controller medications included anti-inflammatory agents, long-acting bronchodilators, and leukotriene modifiers.
Participants in the trial ranged from six to 17 years of age, had asthma symptoms, had been diagnosed with asthma by a physician, and were allergic to at least one indoor allergen.